Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Anne Øvrehus"'
Autor:
Ulrik Fahnøe, Lone Wulff Madsen, Peer Brehm Christensen, Christina Søhoel Sølund, Sarah Mollerup, Mette Pinholt, Nina Weis, Anne Øvrehus, Jens Bukh
Publikováno v:
Microbiology Spectrum, Vol 12, Iss 9 (2024)
ABSTRACT Coinfections with human pegivirus 1 (HPgV-1) are common in chronic hepatitis C virus (HCV) patients. However, little is known about whether HPgV-1 is affected by direct-acting antivirals during HCV treatment. Metagenomic analysis and reverse
Externí odkaz:
https://doaj.org/article/65854ff025304af39a7f4d8aa882c8d7
Autor:
Nina Breinholt Stærke, Joanne Reekie, Henrik Nielsen, Thomas Benfield, Lothar Wiese, Lene Surland Knudsen, Mette Brouw Iversen, Kasper Iversen, Kamille Fogh, Jacob Bodilsen, Maria Ruwald Juhl, Susan Olaf Lindvig, Anne Øvrehus, Lone Wulff Madsen, Vibeke Klastrup, Sidsel Dahl Andersen, Anna Karina Juhl, Signe Rode Andreasen, Sisse Rye Ostrowski, Christian Erikstrup, Thea K. Fischer, Martin Tolstrup, Lars Østergaard, Isik Somuncu Johansen, Jens Lundgren, Ole Schmeltz Søgaard
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-8 (2022)
The SARS-CoV-2 Omicron variant is associated with high rates of vaccine breakthrough infections, but the immunological basis for this is not well characterised. Here, the authors show that increased anti-Spike IgG antibody levels are associated with
Externí odkaz:
https://doaj.org/article/9771622eb003427ea09bd3877a62a247
Autor:
Lone Wulff Madsen, Peer Brehm Christensen, Anne Øvrehus, Dorthe Marie Sjødahl Bryde, Dorte Kinggaard Holm, Søren Thue Lillevang, Christian Nielsen
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 12 (2022)
Reducing the treatment duration for chronic hepatitis C could be an important tool in the effort to reach the elimination goals set by the World Health Organization. The current challenge is to predict the target group who will achieve sustained viro
Externí odkaz:
https://doaj.org/article/2ecc23ad25874909971a782b1e734c21
Autor:
Anna Christine Nilsson, Dorte Kinggaard Holm, Ulrik Stenz Justesen, Thøger Gorm-Jensen, Nanna Skaarup Andersen, Anne Øvrehus, Isik Somuncu Johansen, Jens Michelsen, Ulrik Sprogøe, Søren Thue Lillevang
Publikováno v:
International Journal of Infectious Diseases, Vol 103, Iss , Pp 381-388 (2021)
Objectives: Evaluate six commercial serological assays for detection of IgA, IgM or IgG SARS-CoV-2 antibodies in different disease severities. Methods: Three lateral flow tests (LFTs) (Acro IgM/IgG, CTK IgM/IgG, Livzon IgM/IgG) and three ELISA assays
Externí odkaz:
https://doaj.org/article/038bac766a8f4b9f98e8aa3d61ed86ce
Autor:
Lone Wulff Madsen, Susan Olaf Lindvig, Line Dahlerup Rasmussen, Fredrikke Christie Knudtzen, Christian B. Laursen, Anne Øvrehus, Stig Lønberg Nielsen, Isik Somuncu Johansen
Publikováno v:
International Journal of Infectious Diseases, Vol 102, Iss , Pp 212-219 (2021)
Objectives: We aimed to describe clinical characteristics and outcomes of admitted COVID-19 patients in a Danish hospital setting where an early active government intervention was taken. Methods: Prospective cohort study including all admitted patien
Externí odkaz:
https://doaj.org/article/0e4243ae00fc47a19296c3cb8c26db20
Autor:
Lone W. Madsen, Peer B. Christensen, Janne F. Hansen, Birgit T. Røge, Dorte K. Holm, Sandra Dröse, Anne Øvrehus
Publikováno v:
Viruses, Vol 14, Iss 3, p 614 (2022)
Enhancing treatment uptake for hepatitis C to achieve the elimination goals set by the World Health Organization could be achieved by reducing the treatment duration. The aim of this study was to compare the sustained virological response at week 12
Externí odkaz:
https://doaj.org/article/6217b160f14447b08a2265c7d2ba9097
Publikováno v:
BMJ Open, Vol 10, Iss 11 (2020)
Introduction Injecting drug use is the primary driver of hepatitis C virus (HCV) infection in Europe. Despite the need for more engagement with care, people who inject drugs (PWID) are hard to reach with HCV testing and treatment. We initiated a stud
Externí odkaz:
https://doaj.org/article/70b87b39db924f0fab6d17c1137630df
Autor:
Stine Nielsen, Janne Fuglsang Hansen, Gordon Hay, Susan Cowan, Peter Jepsen, Lars Haukali Omland, Henrik Bygum Krarup, Jacob Søholm, Jeffrey V Lazarus, Nina Weis, Anne Øvrehus, Peer Brehm Christensen
Publikováno v:
PLoS ONE, Vol 15, Iss 9, p e0238203 (2020)
BackgroundChronic hepatitis C (CHC) can be eliminated as a public health threat by meeting the WHO targets: 90% of patients diagnosed and 80% treated by 2030. To achieve and monitor progress towards elimination, an updated estimate of the size of the
Externí odkaz:
https://doaj.org/article/3ef46cc9fa204d8ea3838ee905db77fe
Autor:
Jacob Søholm, Janne Fuglsang Hansen, Belinda Mössner, Birgit Thorup Røge, Alex Lauersen, Jesper Bach Hansen, Nina Weis, Toke Seierøe Barfod, Suzanne Lunding, Anne Øvrehus, Rajesh Mohey, Peter Thielsen, Peer Brehm Christensen
Publikováno v:
PLoS ONE, Vol 15, Iss 12, p e0243725 (2020)
Background and aimsTo evaluate the ability of pretreatment liver stiffness measurements (pLSM) to predict hepatocellular carcinoma (HCC), incident decompensation and all-cause mortality in chronic hepatitis C (CHC) patients who achieved sustained vir
Externí odkaz:
https://doaj.org/article/578a81fb836d444dad4a1943a01d9565
Autor:
Olav Dalgard, Ola Weiland, Geir Noraberg, Lars Karlsen, Lars Heggelund, Martti Färkkilâ, Ulla Balslev, Erika Belard, Anne Øvrehus, Mette Skalshøi Kjær, Henrik Krarup, Birgit Thorup Røge, Sofie Hallager, Lone G Madsen, Alex Lund Laursen, Martin Lagging, Nina Weis
Publikováno v:
PLoS ONE, Vol 12, Iss 7, p e0179764 (2017)
Chronic hepatitis C virus (HCV) genotype 3 infection with advanced liver disease has emerged as the most challenging to treat. We retrospectively assessed the treatment outcome of sofosbuvir (SOF) based regimes for treatment of HCV genotype 3 infecti
Externí odkaz:
https://doaj.org/article/c96e7f90a1224916ae10a8afbc4b5c77